38th European College of Neuropsychopharmacology (ECNP) Congress
Prof. Pallanti is currently an Ambassador and was a member of the Executive Board of the ECNP (European College of Neuropsychopharmacology) from 2016 to 2019.
This year, Prof. Pallanti is presenting his poster on “Alpha (10Hz) vs Gamma (40Hz) Photobiomodulation in Mild Cognitive Impairment: Predictors of Response and Specific Outcomes” and is participating, as a founding member, in the ECNP Neuromodulation Network meeting.
Course Details
📅 Date: 11 – 14 October 2025
📍 Location: RAI Amsterdam, Europaplein 24, 1078 GZ Amsterdam, The Netherlands
Download the programme: https://www.ecnp.eu/congress2025/programme/
The ECNP (European College of Neuropsychopharmacology) is the leading European non-profit association that promotes research and treatment of brain disorders through applied neuroscience and translational medicine.
The mission of the ECNP is to ensure that advances in understanding brain function and human behavior are translated into better treatments and improved public health.
The ECNP Annual Meeting, officially the European College of Neuropsychopharmacology (ECNP) Congress, is Europe's premier annual event for applied and translational neuroscience, bringing together ~7,000 international professionals to advance the understanding and treatment of brain disorders. (https://www.ecnp.eu/congress2025/)
ECNP is a European scientific association. Its core is around 1,000 personal members, who are researchers, clinicians and allied professionals in the fields of translational neuroscience and applied brain research. Most are in Europe, though members come from around the world. The larger ECNP community embraces all those who are committed to translating discoveries in brain science into new and better treatments for disorders of the brain.
ECNP is a non-profit organisation, independent, self-funded and apolitical. It is not aligned to any government or country and does not espouse any political agenda.
The origins of the College lie in pharmacology and the science of developing compounds that act on the central nervous system to treat the symptoms of neuropsychiatric conditions. Today, however, ECNP embraces all forms of brain research as it applies to human brain disorders. This covers all kinds of treatments, including not just medicines, but talking therapies, neuromodulation, and technology-enabled e-health.
ECNP’s core mission is to help ensure that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health.
The annual ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Held every autumn, the ECNP Congress brings together psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of brain disorders.
